De Rucci Healthy Sleep Co., Ltd. (SHE:001323)
China · Delayed Price · Currency is CNY 18.60
-0.06 (-0.32%)
Jun 10, 2026, 3:04 PM CST
De Rucci Healthy Sleep Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 5,209 | 5,144 | 5,522 | 5,516 | 5,757 | 6,416 |
Other Revenue | 83.44 | 83.44 | 80.7 | 62.35 | 55.31 | 64.86 |
| 5,293 | 5,227 | 5,603 | 5,579 | 5,813 | 6,481 | |
Revenue Growth (YoY) | -4.17% | -6.71% | 0.43% | -4.03% | -10.31% | 45.56% |
Cost of Revenue | 2,592 | 2,553 | 2,802 | 2,775 | 3,113 | 3,568 |
Gross Profit | 2,701 | 2,674 | 2,801 | 2,803 | 2,699 | 2,913 |
Selling, General & Admin | 2,016 | 1,932 | 1,713 | 1,709 | 1,769 | 1,911 |
Research & Development | 234.21 | 224.28 | 205.28 | 185.76 | 158.29 | 155.08 |
Other Operating Expenses | 38.46 | 42.47 | 40.51 | 36.3 | 46.99 | 46.81 |
Operating Expenses | 2,293 | 2,203 | 1,961 | 1,928 | 1,981 | 2,116 |
Operating Income | 408.25 | 470.24 | 840.48 | 875.48 | 718.6 | 797.17 |
Interest Expense | -21.65 | -19.68 | -17.88 | -8.79 | -9.28 | -10.85 |
Interest & Investment Income | 46.96 | 51.15 | 65.88 | 73.24 | 58.83 | 39.77 |
Currency Exchange Gain (Loss) | -8.71 | -8.71 | -4.13 | 0.83 | -5.34 | -6.55 |
Other Non Operating Income (Expenses) | -8.39 | -9.04 | -2.98 | -8.59 | -8.25 | -9.1 |
EBT Excluding Unusual Items | 416.47 | 483.97 | 881.38 | 932.17 | 754.56 | 810.44 |
Gain (Loss) on Sale of Investments | 118.15 | 105.46 | 21.42 | 0.39 | 0.74 | - |
Gain (Loss) on Sale of Assets | 3.19 | 2.57 | -8 | 7.17 | 29.31 | -4.52 |
Asset Writedown | -0.26 | -0.14 | -1.4 | -7.41 | -1.11 | -0.39 |
Other Unusual Items | 25.75 | 25.75 | 25.34 | 26.98 | 35.91 | 10.28 |
Pretax Income | 563.3 | 617.61 | 918.73 | 959.31 | 819.4 | 817.82 |
Income Tax Expense | 65.86 | 89.43 | 151.4 | 157.04 | 111 | 131.37 |
Earnings From Continuing Operations | 497.45 | 528.18 | 767.33 | 802.27 | 708.41 | 686.44 |
Minority Interest in Earnings | 8.42 | 7.35 | - | - | - | - |
Net Income | 505.86 | 535.53 | 767.33 | 802.27 | 708.41 | 686.44 |
Net Income to Common | 505.86 | 535.53 | 767.33 | 802.27 | 708.41 | 686.44 |
Net Income Growth | -32.02% | -30.21% | -4.35% | 13.25% | 3.20% | 27.99% |
Shares Outstanding (Basic) | 430 | 432 | 434 | 439 | 419 | 395 |
Shares Outstanding (Diluted) | 430 | 432 | 434 | 439 | 419 | 395 |
Shares Change (YoY) | -1.64% | -0.38% | -1.26% | 4.80% | 5.98% | 12.57% |
EPS (Basic) | 1.18 | 1.24 | 1.77 | 1.83 | 1.69 | 1.74 |
EPS (Diluted) | 1.18 | 1.24 | 1.77 | 1.83 | 1.69 | 1.74 |
EPS Growth | -30.88% | -29.94% | -3.14% | 8.07% | -2.62% | 13.69% |
Free Cash Flow | 238.32 | 162.01 | 709.84 | 1,539 | 25.7 | 226.43 |
Free Cash Flow Per Share | 0.55 | 0.38 | 1.64 | 3.50 | 0.06 | 0.57 |
Dividend Per Share | 1.450 | 1.450 | 1.591 | 0.909 | 1.818 | - |
Dividend Growth | -8.86% | -8.86% | 75.00% | -50.00% | - | - |
Gross Margin | 51.03% | 51.15% | 49.99% | 50.25% | 46.44% | 44.94% |
Operating Margin | 7.71% | 9.00% | 15.00% | 15.69% | 12.36% | 12.30% |
Profit Margin | 9.56% | 10.25% | 13.70% | 14.38% | 12.19% | 10.59% |
Free Cash Flow Margin | 4.50% | 3.10% | 12.67% | 27.59% | 0.44% | 3.49% |
EBITDA | 630.37 | 692.25 | 1,062 | 1,069 | 893.41 | 925.05 |
EBITDA Margin | 11.91% | 13.24% | 18.96% | 19.17% | 15.37% | 14.27% |
D&A For EBITDA | 222.11 | 222.01 | 221.61 | 193.93 | 174.81 | 127.89 |
EBIT | 408.25 | 470.24 | 840.48 | 875.48 | 718.6 | 797.17 |
EBIT Margin | 7.71% | 9.00% | 15.00% | 15.69% | 12.36% | 12.30% |
Effective Tax Rate | 11.69% | 14.48% | 16.48% | 16.37% | 13.55% | 16.06% |
Revenue as Reported | 5,293 | 5,227 | 5,603 | 5,579 | 5,813 | 6,481 |
Advertising Expenses | - | 883.03 | 768.93 | 753.11 | 756.49 | 831.77 |